Early myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI)

Xichun Yu; Tesiram, Yasvir A.; Towner, Rheal A.; Abbott, Andrew; Patterson, Eugene; Shijun Huang; Garrett, Marion W.; Chandrasekaran, Suresh; Matsuzaki, Satoshi; Szweda, Luke I.; Gordon, Brian E.; Kem, David C.
January 2007
Cardiovascular Diabetology;2007, Vol. 6, p6
Academic Journal
Background: Diabetes is associated with a cardiomyopathy that is independent of coronary artery disease or hypertension. In the present study we used in vivo magnetic resonance imaging (MRI) and echocardiographic techniques to examine and characterize early changes in myocardial function in a mouse model of type 1 diabetes. Methods: Diabetes was induced in 8-week old C57BL/6 mice with two intraperitoneal injections of streptozotocin. The blood glucose levels were maintained at 19-25 mmol/l using intermittent low dosages of long acting insulin glargine. MRI and echocardiography were performed at 4 weeks of diabetes (age of 12 weeks) in diabetic mice and age-matched controls. Results: After 4 weeks of hyperglycemia one marker of mitochondrial function, NADH oxidase activity, was decreased to 50% of control animals. MRI studies of diabetic mice at 4 weeks demonstrated significant deficits in myocardial morphology and functionality including: a decreased left ventricular (LV) wall thickness, an increased LV end-systolic diameter and volume, a diminished LV ejection fraction and cardiac output, a decreased LV circumferential shortening, and decreased LV peak ejection and filling rates. M-mode echocardiographic and Doppler flow studies of diabetic mice at 4 weeks showed a decreased wall thickening and increased E/A ratio, supporting both systolic and diastolic dysfunction. Conclusion: Our study demonstrates that MRI interrogation can identify the onset of diabetic cardiomyopathy in mice with its impaired functional capacity and altered morphology. The MRI technique will lend itself to repetitive study of early changes in cardiac function in small animal models of diabetic cardiomyopathy.


Related Articles

  • Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Hassouna, Ashraf; Loubani, Mahmoud; Matata, Bashir M.; Fowler, Alan; Standen, Nicholas B.; Gali�anes, Manuel // Cardiovascular Research;Feb2006, Vol. 69 Issue 2, p450 

    Abstract: Objectives: We have shown previously that human diabetic myocardium cannot be preconditioned. Here, we have investigated the basis of this cardioprotective deficit. Methods: Right atrial sections from four patient groups�non-diabetic, insulin-dependent diabetes mellitus (IDDM),...

  • New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes. W Crasto // Postgraduate Medical Journal;May2009, Vol. 85 Issue 1003, p257 

    Effective glycaemic control can reduce and potentially prevent the microvascular and macrovascular complications of diabetes. Insulin is the mainstay of treatment for type 1 diabetes and is indicated in patients with type 2 diabetes who do no achieve optimal glycaemic control despite the use of...

  • Imaging of the brain in children with type I diabetes mellitus. Wootton-Gorges, Sandra; Glaser, Nicole S. // Pediatric Radiology;Sep2007, Vol. 37 Issue 9, p863 

    Type 1 diabetes mellitus (DM) affects about 1 in 500 children and can cause damage to multiple organ systems. In recent years, growing attention has been given to the effects of type 1 DM on the brain. In this article we review important imaging features of the brain in children with type 1 DM,...

  • Citations and Clinicians' Notes: Management: Oral Hypoglycaemic Agents.  // Current Medical Literature: Diabetes;2003, Vol. 20 Issue 4, p118 

    Presents citations and clinicians' notes on the use of oral hypoglycemic agents for the management of diabetes. Efficacy and safety of combined insulin and metformin treatment in patients with type 2 diabetes; Effect of rosiglitazone in patients with type 2 diabetes mellitus; Safety and...

  • The Death of a Child With Diabetes from Neglect. Geffken, Gary; Bennett Johnson, Suzanne; Silverstein, Janet; Rosenbloonfi, Arlan // Clinical Pediatrics;Jun1992, Vol. 31 Issue 6, p325 

    This case report of a child with insulin-dependent diabetes mellitus (IDDM) describes a naturally occurring ABABCA design. The A condition represents poor diabetes management provided in the home setting, and the B and C conditions represent improved diabetes management in residential treatment...

  • Advances in Diabetes Therapies. Unger, Jeff // Clinician Reviews;Apr2012 Supplement, pS19 

    The article reports on the developments in diabetes treatment as of April 2012. Insulin degludec (IDeg), an ultra long-acting basal insulin analog, helps achieve optimal glycemic control but with low risk for hypoglycemia. A single daily dose of dapagliflozin helps patients reduce A1C levels,...

  • Recurrent Hepatomegaly and Transient Alteration of Liver Functions in an Adolescent with Diabetic Acidosis. Ruschhaupt, David G.; Rennert, Owen M. // Clinical Pediatrics;Feb1970, Vol. 9 Issue 2, p122 

    The article presents information on the recurrence of hepatomegaly and transient alteration of liver functions in an adolescent with diabetic acidosis. Diabetes mellitus is associated with hepatomegaly, variously ascribed to fatty infiltration 1 or glycogen deposition. The liver is capable of...

  • The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0—34 years group in Sweden 1983 to 1998 A. Pundziute-LyckÃ¥ et al.: Type I diabetes in the 0—34 years group in Sweden. Pundziute-Lyckå, A.; Dahlquist, G.; Nyström, L.; Arnqvist, H.; Björk, E.; Blohmé, G.; Bolinder, J.; Eriksson, J. W.; Sundkvist, G.; Östman, J. // Diabetologia;Jun2002, Vol. 45 Issue 6, p783 

    Aims/hypothesis. To analyse the incidence of Type I (insulin-dependent) diabetes mellitus in the 0–34 years age group in Sweden 1983–1998. Methods. Incidence and cumulative incidence per 100 000 and Poisson regression analysis of age-period effects was carried out using 11 751...

  • Red carpeting the newer antidiabetics. Gude, Dilip // Journal of Pharmacology & Pharmacotherapeutics;Apr2012, Vol. 3 Issue 2, p127 

    The rapidly increasing prevalence of diabetes on a global scale beseeches an urgent need for newer and better treatment options. Our better understanding of the pathophysiology of diabetes has enabled a continual churn out of newer antidiabetic agents with varying modes of action. Sodium-Glucose...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics